Affinity Asset Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.76M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $252K | Sell |
|
|||||
|
2024
Q3 | $4.25M | Sell |
|
|||||
|
2024
Q2 | $17.6M | Sell |
|
|||||
|
2024
Q1 | $21.4M | Buy |
|
|||||
|
2023
Q4 | $15.9M | Buy |
|
|||||
|
2023
Q3 | $4.13M | Buy |
|
|||||
|
2023
Q2 | $2.95M | Buy |
|
|||||
|
2023
Q1 | $1.8M | Sell |
|
|||||
|
2022
Q4 | $4.9M | Buy |
|
|||||
|
2022
Q3 | $2.25M | Buy |
|
|||||
|
2022
Q2 | $1.08M | Sell |
|
|||||
|
2022
Q1 | $4.26M | Buy |
|
|||||
|
2021
Q4 | $3.86M | Buy |
|
|||||
|
2021
Q3 | $2.17M | Sell |
|
|||||
|
2021
Q2 | $1.67M | Sell |
|
|||||
|
2021
Q1 | $2.68M | Buy |
|
|||||
|
2020
Q4 | $1.31M | Buy |
|